Back to search

University of British Columbia

Dissecting the cell of origin and progression events of DICER1 syndrome-associated sarcoma

Abstract

dc:description

DICER1 syndrome is a rare genetic disorder driven by germline DICER1 inactivating pathogenic variants that predispose pediatric and young adult patients to cancers at various sites. The second, missense mutation in RNase IIIb domain on the alternate allele leads to partial inactivation, compromising its capability in the processing of its targets, e.g., microRNAs. Malignant tumours at various sites are mostly sarcomas that are histologically and molecularly similar, suggesting a shared cellular origin and oncogenic mechanisms. Recently, the Huntsman laboratory has developed a lineage-traceable genetically engineered mouse model that allows for controlled activation of Dicer1 biallelic mutations in Hic1⁺ mesenchymal stromal cells, resulting in the development of renal tumours resembling the human DICER1 sarcoma histologically and molecularly. To uncover the cellular origin and developmental hierarchy, I utilized this model and relevant control lines to dissect the tumour development trajectory. Single-cell transcriptomics analysis of 5 primary tumours revealed a Hic1⁺Pdgfra⁺Mfap4⁺ fibroblastic progenitor population that was identified as universal fibroblasts at normal kidneys. These cells have the capacity to undergo rhabdomyoblastic differentiation or transition into proliferative sarcomatous cells. To facilitate mechanistic characterization, we derived 5 cell lines from primary murine tumours, and 4 of which harboured de novo Trp53 and Kras mutations. Trp53-mutant cells were more resistant to chemotherapies such as vincristine and doxorubicin currently used to treat pleuropulmonary blastoma, the most common DICER1 sarcoma. To identify tumour progression events and associated targetable, perturbed pathways, I performed a curated CRISPR/Cas9 knockout screen for 484 tumour suppressor genes in the cell line harbouring no obvious secondary mutations. Tumour suppressors such as Trp53, Pten, Cdkn2b (p15), Nf1, and Sav1 were identified as candidates. The relevance to disease progression was supported by higher frequency of their protein losses in more advanced DICER1 sarcomas. Loss of Sav1, an effector of the Hippo pathway, is partially correlated with YAP nuclear translocation that promotes proliferation. Activation of MAPK/ERK and inactivation of the Hippo pathway were observed in more advanced DICER1 sarcomas, suggesting synergistic treatment would be beneficial. Overall, our work uncovers a fibroblastic origin for DICER1 sarcoma and identifies critical progression events, providing rationale for a more targeted therapeutic approach.

Degree

thesis:*
Name thesis:degree_name
Doctor of Medicine / Doctor of Philosophy - MD/PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pathology and Laboratory Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zhang, Yu Han (Joyce)
Contributors dc:contributor
  • Huntsman, David G.
  • Wang, Yemin

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/91375

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Zhang, Yu Han (Joyce). Dissecting the cell of origin and progression events of DICER1 syndrome-associated sarcoma. doctoral thesis, University of British Columbia, 2025. http://hdl.handle.net/2429/91375